Whistleblower News
-
Former GSK VP Indicted Again
Apr 15
Posted by: Staff | Number of Comments: Comments Off
Category: Whistleblower News | Date Posted: Friday, April 15th, 2011
A former VP and associate general counsel for GSK, is back in the courthouse. After being indicted for obstructing an official proceeding, concealing and falsifying records and making false statements to the FDA back in November 2010, she was able to get the charges dismissed because prosecutors “misinstructed” a grand juror as to a question about a central legal point. However, the judge’s dismissal left open the possibility of re-indicting Ms. Stevens. This has now happened.
Read more: http://www.modernhealthcare.com/article/20110414/N… -
Safety Concerns at California Nuclear Plant Cause One Whistleblower To Step Forward
Apr 14
Posted by: Staff | Number of Comments: Comments Off
Category: Whistleblower News | Date Posted: Thursday, April 14th, 2011
With all the focus on nuclear plants from the recent earthquake and tsunami in Japan, a whistleblower at one of California’s nuclear plants has stepped forward with claims of retaliation after reporting safety concerns.
Read more:http://www.ottawacitizen.com/technology/Whistleblower+files+suit+against+nuclear+plant/4565888/story.html…
-
New Money-Laundering Whistleblower Program in Mexico
Apr 12
Posted by: Staff | Number of Comments: Comments Off
Category: Whistleblower News | Date Posted: Tuesday, April 12th, 2011
With increasing drug violence, the Mexican Attorney General’s office is instituting a new program for whistleblowers on money-laundering. The whistleblowers stand to collect up to one fourth of the total recovery.
Read more: http://www.reuters.com/article/2011/04/06/mexico-whistleblower-idUSN0620658120110406…
-
Whistleblower Suits Do Not Violate 1st Amendment
Mar 31
Posted by: Staff | Number of Comments: Comments Off
Category: Whistleblower News | Date Posted: Thursday, March 31st, 2011
The 4th Circuit Court of Appeals heard arguments about whether the False Claims Act provision that seals lawsuits from public disclosure violates the First Amendment. The U.S. Court of Appeals upheld the lower court’s decision that extending the 60-day seal period does not violate the constitution.
Click here to read more…. -
Ninth Circuit decision makes it harder to bring a Federal False Claims Act case
Mar 31
Posted by: Staff | Number of Comments: Comments Off
Category: Whistleblower News | Date Posted: Thursday, March 31st, 2011
In Cafasso v. General Dynamics, the Ninth Circuit Court of Appeals ruled that FCA complaints can not merely allege “unsavory conduct…[U]nsavory conduct is not, without more, actionable under the [False Claims Act].” The court goes on to say that FCA actions must “state with particularity the circumstances constitute fraud or mistake,” as well as, “plead plausible allegations.” The court’s decision forces FCA cases to clear a higher bar.
Click here to read more…. -
IRS gives $1.1 million to Whistleblower at Enron
Mar 23
Posted by: Staff | Number of Comments: Comments Off
Category: Whistleblower News | Date Posted: Wednesday, March 23rd, 2011
The whistleblower who revealed the tax fraud at Enron is in for a big pay day. The IRS Whistleblower Office will be giving him or her $1.1 million. Unfortunately for the whistleblower, this payout is under older rules that give less money. Today, if you blow the whistle and the IRS recovers over $2 million, you can get up to 30% of the recovered money. According to the whistleblower’s firm, Phillips & Cohen, this person wishes to remain anonymous, but we do know that he or she is a Wall Street banker.
Read more at MSN:http://money.ms…
-
Big Pharma’s Sugared Pills
Mar 16
Posted by: Staff | Number of Comments: Comments Off
Category: Whistleblower News | Date Posted: Wednesday, March 16th, 2011
By Andrew Jack, Financial Times
Published March 11, 2011Read it here.
Or if you have a FT subscription: http://www.ft.com/cms/s/0/ae7099a0-49bc-11e0-acf0-00144feab49a.html#axzz1GnR32mEN…
-
Rapamune In the News
Feb 8
Posted by: Staff | Number of Comments: Comments Off
Category: Whistleblower Case Studies, Whistleblower News | Date Posted: Tuesday, February 8th, 2011
U.S. Joins Whistle-Blower Suit Against Pfizer-NY Times…
-
U.S. Lawmakers to Investigate Wyeth Illegal Marketing
Oct 29
Posted by: Staff | Number of Comments: Comments Off
Category: Whistleblower Case Studies, Whistleblower News | Date Posted: Friday, October 29th, 2010
U.S. Lawmakers to Investigate Wyeth Illegal Marketing…
-
Rapamune
Oct 29
Posted by: Staff | Number of Comments: Comments Off
Category: Whistleblower Case Studies, Whistleblower News | Date Posted: Friday, October 29th, 2010
Grant & Eisenhofer has filed a lawsuit against Wyeth Pharmaceuticals and its parent company, Pfizer, alleging unlawful marketing practices with regard to the immunosuppressant drug, Rapamune. A copy of the lawsuit can be found here….